Tech Company Financing Transactions
Constructive Bio Funding Round
On 9/24/2024, Constructive Bio received $58 million in Series A funding from Ahren Innovation Capital, OMX Ventures and Paladin Capital Group.
Transaction Overview
Company Name
Announced On
9/24/2024
Transaction Type
Venture Equity
Amount
$58,000,000
Round
Series A
Investors
Ahren Innovation Capital (Lead Investor)
OMX Ventures (Lead Investor)
Paladin Capital Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further develop its technology that writes genomes from scratch and creates entirely new biomolecules.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
The Recodery, Lion Works, Station Rd E, Whittlesford
Cambridge, CB22 4WL
UK
Cambridge, CB22 4WL
UK
Phone
Undisclosed
Website
Email Address
Overview
We are pioneers of genome writing and genetic code reprogramming. We explore unchartered chemical space to build programmable biomolecules beyond what nature can do, with applications across industries. We rewrite the genetic code of living cells to enable them to produce novel classes of biomolecules from therapeutics to biomaterials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ola Wlodek
Chief Financial Officer
Solange Bullukian
Chief Scientific Officer
Jason Chin
VP - Administration
Helena Francis
VP - Bus. Development
Paul Wallace
VP - R & D
Daniel de la Torre
Browse more venture capital transactions:
Prev: 9/24/2024: Arya Health venture capital transaction
Next: 9/24/2024: Atomicwork venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs